NEWSROOM | Galderma

Galderma receives FDA approval for Sculptra® for cheek wrinkles

Augmented reality: patient experience trumps misconceptions around injectables

AMWC 2023: Data from Sculptra® Cheek Wrinkle and Alluzience® Star Studies reinforce strength of Galderma’s broad aesthetic portfolio

AMWC 2023: Data from Galderma's broad aesthetic portfolio

Galderma launches FACE by Galderma™, a cutting-edge aesthetic visualization tool that simulates injectable treatment results in real-time

AAD 2023: Late-Breaking Phase III results demonstrate nemolizumab’s significant impact on prurigo nodularis

AAD 2023: Extensive updates from Galderma’s broad and innovative portfolio through posters and presentation sessions

Cetaphil Celebrates Global Initiative Highlighting Sensitive Skin with a Month of Skin Science Education

Galderma delivers strong FY 2022 growth driven by innovation and commercial performance

Cetaphil® unveils digital AI skin analysis tool to empower and educate users with sensitive skin

Cetaphil raises awareness of the connection between clothing and sensitive skin

Galderma Launches Cutting-Edge Formulation With Alastin Skincare® Resurface Skin Polish Developed To Uncover Visibly Glowing Skin

Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction